Innovation Pharmaceuticals Inc (IPIX)

[frrol]

We should keep in mind the dosing regimen of the Kevetrin Phase 1 at Dana-Farber in view of our ultimate conclusion on its PK. I have no expectations for efficacy from that trial, nor was any given except for a few anecdotal incidences, which for anyone familiar with cancer would know are not reliable indications of anything. (Cancers can have inexplicable and un-attributable behaviors on their own.) Given the non-therapeutic dosing and limited duration I suspect that, unfortunately, no one was 'cured'. We obviously have not heard of any.

What is good news at least, or a "nice to hear", is that the D-F researchers wanted to be involved in future clinical trials. It means they are optimistic, not just us.

We can't borrow money to fund our trials. We don't have collateral or cash flow to borrow against. Our capital has to come from equity raises or partners. Which is what we're doing, of course.

I think our extensive and successful Phase 1 is a selling point for a deal. So is the (very, very limited) Phase 2. But I do not know how much for the latter; my point is that it is doubtful a bit doubtful so I'll be surprised if K is in "advanced negotiations". If it is, no doubt it is at least contingent on the pill completion (and perhaps more).